Cardwell B A, Nakai B
University of Minnesota School of Medicine, Anoka, USA.
Convuls Ther. 1995 Jun;11(2):110-3.
We examined the medical records of electroconvulsive therapy (ECT) recipients who concurrently received clozapine (n = 7). The patients tolerated ECT, with standard electrical stimulus parameters, without complications. No patients had tardive seizures. The seizure duration during ECT increased, as recorded by electroencephalogram and cuff technique, nonsignificantly by a mean of +2.4 s (range of duration: 17-54 s) while on clozapine. Patient response as evaluated with Brief Psychiatric Rating Scale scores showed a total improvement of 26.9%, improvement in positive signs of schizophrenia of 25.3%, and improvement in negative signs of 21.3%. Hallucinatory behavior (41.7%) and disorganization (45.5%) were markedly reduced. Combined clozapine and ECT appears as safe as other neuroleptics with ECT, with comparable clinical improvements.
我们检查了同时接受氯氮平治疗的电休克治疗(ECT)患者的病历(n = 7)。患者耐受ECT,采用标准电刺激参数,未出现并发症。无患者发生迟发性癫痫。在服用氯氮平期间,通过脑电图和袖带技术记录,ECT期间的癫痫发作持续时间平均非显著性增加2.4秒(持续时间范围:17 - 54秒)。用简明精神病评定量表评分评估的患者反应显示,总体改善率为26.9%,精神分裂症阳性症状改善率为25.3%,阴性症状改善率为21.3%。幻觉行为(41.7%)和紊乱(45.5%)明显减少。氯氮平与ECT联合使用似乎与其他抗精神病药物与ECT联合使用一样安全,临床改善效果相当。